#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Gastroenterology and Hepatology / 2026 - 2

Mapování horizontu léčby ulcerózní kolitidy v éře inhibitorů IL-23

Download PDF

Published in: Gastroent Hepatol 2026; 80(2): 183-185
Category:

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Editorial
Benefits and risks of HCV cure
Donation after circulatory death (DCD): the need to implement a program in Slovakia
Neutrophil-to-lymphocyte ratio refl ects infl ammatory phenotypes of alcohol-associated hepatitis: diff erences between mild and severe dis ease
A rare cause of headache in a liver transplant patient –  a case report
Diagnosis and therapy of hepatitis B virus infection: Czech national guidelines
Impact of successful iron deficiency anemia correction with iron carboxymaltose on quality of life, treatment adherence, and exacerbation frequency in inflammatory bowel dis­ease patients
Potential therapeutic targets for the treatment of inflammatory bowel dis­eases
Milestones in the research, development, and therapeutic use of infliximab
The selection from international journals
Správná odpověď na předchozí kvíz
Subkutánní infliximab – zlepšování výsledků léčby pacientů s IBD
O subkutánním infliximabu třikrát jinak a do hloubky
Article was published in

Gastroenterology and Hepatology

Issue 2
2026 Issue 2
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#